These analyses are of utmost relevance in neuroblastomas without MYCN-amplification, TERT rearrangement, and ATRX alterations, as these neuroblastomas are most likely low-risk, but the detection of telomerase overexpression or ALT would still render them high-risk. The gene discussed is GPT; the disease is neuroblastoma.